CNTB Competitors & Alternatives
Compare Connect Biopharma Holdings Ltd with similar stocks in the same industry
Biotechnology
CNTB
Main Stock$0.61
-5.07%
Tradestie Score
40
Market Cap
$83.60M
Revenue Growth
56.7%
Analyst Upside
+883.0%
Supply-Chain & Ecosystem Map (Customers, Suppliers & Direct Competitors)
Bottleneck Score: 2/10
Drug Discovery Biotech
Drug Design
Top Competitors
220 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
CLYM
Climb Bio, Inc. Common Stock
|
$9.63
-3.12%
|
$133.50M | - | 45 | Compare |
|
SRZN
Surrozen, Inc. Common
|
$30.16
-6.68%
|
$117.07M | - | 33 | Compare |
|
ANRO
Alto Neuroscience Inc.
|
$25.11
-7.41%
|
$110.20M | - | 34 | Compare |
|
ADAG
Adagene Inc. American Depositary Shares
|
$1.56
-2.50%
|
$94.26M | - | 38 | Compare |
|
ENTX
Entera Bio Ltd. Ordinary Shares
|
$3.03
+0.17%
|
$84.52M | - | 53 | Compare |
|
UNCY
Unicycive Therapeutics, Inc. Common Stock
|
$3.73
+0.68%
|
$78.68M | - | 42 | Compare |
|
ALGS
Aligos Therapeutics, Inc. Common Stock
|
$1.41
-15.06%
|
$71.53M | - | 38 | Compare |
|
IMMX
Immix Biopharma, Inc. Common Stock
|
$7.20
-3.74%
|
$67.94M | - | 52 | Compare |
|
INAB
IN8bio, Inc. Common Stock
|
$0.86
+5.47%
|
$10.26M | - | 52 | Compare |
|
DRMA
Dermata Therapeutics, Inc. Common Stock
|
$0.58
-3.14%
|
$3.50M | - | 42 | Compare |
More CNTB Analysis
Data updated: Nov 17, 2026 | Industry: Biotechnology (SIC 2834)
220 stocks in this industry